Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Falk

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Postgraduate Medical Journal|March 1, 1979
Ventricular fibrillation following high potency intravenous vitamin injectionR H Falk, D E Protheroe
The American Journal of Cardiology|April 1, 1990
Paradoxical increase in heart rate before conversion to sinus rhythm in patients with recent-onset atrial fibrillationA A Knowlton, R H Falk
Chest|October 1, 1984
Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmiasR H Falk, J L O'Brien
Annals of Internal Medicine|April 1, 1991
Digoxin for atrial fibrillation: a drug whose time has gone?R H Falk, J I Leavitt
The American Journal of Cardiology|August 12, 2000
S1 in Wolff-Parkinson-White syndromeM F Khan, R H Falk
American Heart Journal|October 31, 2000
Dofetilide: a new pure class III antiarrhythmic agentR H Falk, J M Decara
Archives of Internal Medicine|September 1, 1982
The heart in sickle cell anemiaR H Falk, W B Hood
Journal of Cardiovascular Electrophysiology|November 1, 1994
FlecainideR H Falk, R I Fogel
Journal of the American College of Cardiology|May 15, 1998
Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion?R H Falk, J Decara, V Abascal
The New England Journal of Medicine|September 26, 1997
The systemic amyloidosesR H Falk, R L Comenzo, M Skinner
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Postgraduate Medical Journal|March 1, 1979
Ventricular fibrillation following high potency intravenous vitamin injectionR H Falk, D E Protheroe
The American Journal of Cardiology|April 1, 1990
Paradoxical increase in heart rate before conversion to sinus rhythm in patients with recent-onset atrial fibrillationA A Knowlton, R H Falk
Chest|October 1, 1984
Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmiasR H Falk, J L O'Brien
Annals of Internal Medicine|April 1, 1991
Digoxin for atrial fibrillation: a drug whose time has gone?R H Falk, J I Leavitt
The American Journal of Cardiology|August 12, 2000
S1 in Wolff-Parkinson-White syndromeM F Khan, R H Falk
American Heart Journal|October 31, 2000
Dofetilide: a new pure class III antiarrhythmic agentR H Falk, J M Decara
Archives of Internal Medicine|September 1, 1982
The heart in sickle cell anemiaR H Falk, W B Hood
Journal of Cardiovascular Electrophysiology|November 1, 1994
FlecainideR H Falk, R I Fogel
Journal of the American College of Cardiology|May 15, 1998
Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion?R H Falk, J Decara, V Abascal
The New England Journal of Medicine|September 26, 1997
The systemic amyloidosesR H Falk, R L Comenzo, M Skinner
Pageof 12